Skip to main content Accessibility help
×
×
Home

Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?

  • Garry Walter (a1) (a2), Simon Byrne (a2), Oren Griffiths (a3), Glenn Hunt (a1) (a4), Nerissa Soh (a2), Michelle Cleary (a5), Paul Duffy (a6), Geoff Crawford (a7), Peter Krabman (a8) (a9), Patrick Concannon (a10) and Gin Malhi (a1) (a11)...

Abstract

Walter G, Byrne S, Griffiths O, Hunt G, Soh N, Cleary M, Duffy P, Crawford G, Krabman P, Concannon P, Malhi G. Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Can young people reliably rate side effects of low-dose antipsychotic medication using a self-report survey?
      Available formats
      ×

Copyright

Corresponding author

Professor Garry Walter, Coral Tree Family Service, Northern Sydney Central Coast Health, PO Box 142, North Ryde, NSW 1670, Australia. Tel: +61 2 9887 5830; Fax: +61 2 9887 2941; E-mail: gwalter@mail.usyd.edu.au

References

Hide All
1.Findling, RL.Atypical antipsychotics in the treatment of children and adolescents. J Clin Psychiatry 2004;65(Suppl. 6):329.
2.Olfson, M, Blanco, C, Liu, L, Moreno, C, Laje, G.National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 2006;63:679685.
3.Cheng-Shannon, J, McGough, MD, Pataki, C, McCracken, JT.Second-generation antipsychotic medications in children and adolescents. J Child Adolesc Psychopharmacol 2004;14:372394.
4.Walter, G, Delaroche, A, Soh, Net al. Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Aust Psychiatry 2008;16:253262.
5.Silvaprasad, L, Hassan, T, Handy, S.Survey of atypical antipsychotic medication used by children and adolescent psychiatrists. Child Adolesc Ment Health 2006;11:164167.
6.Doey, T, Handelman, K, Seabrook, JA, Steele, M.Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patient age under 18 years. Can J Psychiatry 2007;52:363368.
7.Efron, D, Hiscock, H, Sewell, JRet al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 2003;111:372375.
8.Croonenberghs, J, Fegert, J, Findling, RL, De Smedt, G, Van Dongen, S.Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients. J Am Acad Child Adolesc Psychiatry 2005;44:6472.
9.Reyes, M, Croonenberghs, J, Augustyns, I, Eerdekens, M.Long-term use of risperidone in children with disruptive behavior disorders and subaverage intelligence: efficacy, safety and tolerability. J Child Adolesc Psychopharmacol 2006;16:260272.
10.Reyes, M, Olah, R, Csaba, K, Augustyns, I, Eerdekens, M.Long-term safety and efficacy of risperidone in children with disruptive behaviour disorders: results of a 2-year extension study. Eur Child Adolesc Psychiatry 2005;15:97104.
11.Correll, CU.Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story. J Clin Psychiatry 2005;66:13311332.
12.Correll, CU.Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 2006;45:771791.
13.Correll, CU.Antipsychotic use in children and adolescents: minimizing adverse effects to maximise outcomes. J Am Acad Child Adolesc Psychiatry 2008;47:920.
14.Awad, AG, Voruganti, LN.Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull 2000;26:557564.
15.Aman, MG, Arnold, E, McDougle, CJet al. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 2005;15:869884.
16.Day, JC, Wood, G, Dewey, M, Bentall, RP.A Self-Rating Scale for Measuring Neuroleptic Side-Effects – validation in a group of schizophrenic patients. Br J Psychiatry 1995;166:650653.
17.Lambert, TJR.Measurement of antipsychotic-induced side-effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol 2003;18:405411.
18.Linjaerde, O, Ahlfors, UG, Bech, P, Dencker, SJ, Elgen, K.The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatr Scand 1987;76:1100.
19.Voruganti, L, Heslegrave, R, Awad, AG, Seeman, MV.Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998;28:165172.
20.Amador, XF, Strauss, DH, Yale, SA, Flaum, MM, Endicott, J, Gorman, JM.Assessment of insight in psychosis. Am J Psychiatry 1993;150:873879.
21.Byrne, S, Walter, G, Hunt, Get al. Duration of treatment and self-reported neuroleptic side-effects of low dose risperidone in children and adolescents. Aust Psychiatry 2010;18:4245.
22.Morrison, P, Gaskill, D, Meehan, T, Lunney, P, Lawrence, G, Collings, P.The use of the Liverpool University Side Effect Rating Scale (LUNSERS) in clinical practice. Aust N Z J Ment Health Nurs 2000;9:166176.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Acta Neuropsychiatrica
  • ISSN: 0924-2708
  • EISSN: 1601-5215
  • URL: /core/journals/acta-neuropsychiatrica
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed